Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Hydrix Limited, established in Mulgrave, Australia, in 1993, is a global provider of product design, engineering, and regulatory compliance solutions. The company extends its reach across Australia, Singapore, Europe, and North America, structuring its operations into two distinct divisions: Hydrix Services and Hydrix Medical. The Hydrix Medical division is particularly focused on innovative cardiovascular technology. This includes "The GUARDIAN," an advanced device for cardiac monitoring and alerts aimed at improving quality of life; the "Phyzhon PHYRARI FFR-Wire," which empowers cardiologists to seamlessly integrate diagnostic assessments with therapeutic procedures like stent placement; and "LUDO," a versatile, pre-configured platform offering essential resources for developing Mechanical Circulatory Support (MCS) pumps. Beyond these specialized medical offerings, Hydrix offers comprehensive services covering the entire product development lifecycle, expert consultation on regulatory and clinical matters, and strategic technology commercialization. Its extensive client base spans numerous industries, including medical, consumer, industrial, utilities, defense, aerospace, and mining sectors. The company adopted its current name, Hydrix Limited, in November 2018, having previously operated as Panorama Synergy Limited.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.